Current analyst assessments
suspended
Not Rated
Kaufen
BUY
BUY
HAEMATO AG (von GBC AG): BUY
Haemato AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
BUY
HAEMATO AG (von GBC AG): BUY
Kaufen
Haemato AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
Haemato AG (von First Berlin Equity Research GmbH): Kaufen
HAEMATO AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
Buy
Haemato AG (von First Berlin Equity Research GmbH): Buy
BUY
HAEMATO AG (von GBC AG): BUY
Kaufen
Haemato AG (von First Berlin Equity Research GmbH): Kaufen
Haemato AG (von First Berlin Equity Research GmbH): Buy
HAEMATO AG (von GBC AG): Buy
Haemato AG (von First Berlin Equity Research GmbH): Buy
HAEMATO AG (von GBC AG): Buy
Haemato AG (von First Berlin Equity Research GmbH): Buy
HAEMATO AG (von GBC AG): Management Interview
Haemato AG (von First Berlin Equity Research GmbH): Buy
HAEMATO AG (von First Berlin Equity Research GmbH): Buy
HAEMATO AG (von First Berlin Equity Research GmbH): Buy
HAEMATO AG (von First Berlin Equity Research GmbH): Buy
HAEMATO AG (von First Berlin Equity Research GmbH): BUY
Info
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.